Trinity Capital Inc. reports developments as an alternative asset manager and specialty lender focused on private credit for growth-oriented companies. Its recurring news includes quarterly financial results, net investment income, NAV movement, new commitments, funded investments, repayments, exits, and portfolio activity across Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences.
Company updates also cover secured loans, equipment financings, warrant and equity investments, sponsored investment funds, SBIC-related activity, and growth-capital facilities for portfolio companies in technology, life sciences, medical technology, energy infrastructure, and other innovation-driven markets.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Trinity Capital (NASDAQ: TRIN, TRINL) announced a $40 million financing facility to support Convergent Dental, the creator of the Solea® dental laser. Of this amount, $20 million has already been drawn, with an option for Convergent to access an additional $20 million, contingent on agreement terms. The Solea® laser technology is unique as it allows for anesthesia-free dental procedures, enhancing patient comfort and operational efficiency for dental practices. This funding aims to help Convergent accelerate its growth and expand the market adoption of its innovative product. Trinity Capital, known for its specialized financial solutions to growth-stage companies, reinforces its commitment to driving advancements in the life sciences sector.